Logo image of MBWS.PA

MARIE BRIZARD WINE & SPIRITS (MBWS.PA) Stock Fundamental Analysis

EPA:MBWS - Euronext Paris - Matif - FR0000060873 - Common Stock - Currency: EUR

3.04  -0.01 (-0.33%)

Fundamental Rating

4

MBWS gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 23 industry peers in the Beverages industry. MBWS has a great financial health rating, but its profitability evaluates not so good. MBWS has a expensive valuation and it also scores bad on growth.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year MBWS was profitable.
In the past year MBWS had a positive cash flow from operations.
In multiple years MBWS reported negative net income over the last 5 years.
The reported operating cash flow has been mixed in the past 5 years: MBWS reported negative operating cash flow in multiple years.
MBWS.PA Yearly Net Income VS EBIT VS OCF VS FCFMBWS.PA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -50M -100M

1.2 Ratios

The Return On Assets of MBWS (3.46%) is comparable to the rest of the industry.
The Return On Equity of MBWS (4.52%) is worse than 82.61% of its industry peers.
With a Return On Invested Capital value of 3.24%, MBWS is not doing good in the industry: 91.30% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA 3.46%
ROE 4.52%
ROIC 3.24%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
MBWS.PA Yearly ROA, ROE, ROICMBWS.PA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -20 -40 -60

1.3 Margins

Looking at the Profit Margin, with a value of 5.12%, MBWS is doing worse than 69.57% of the companies in the same industry.
MBWS's Profit Margin has improved in the last couple of years.
MBWS has a Operating Margin of 4.72%. This is amonst the worse of the industry: MBWS underperforms 91.30% of its industry peers.
MBWS's Operating Margin has improved in the last couple of years.
Looking at the Gross Margin, with a value of 39.05%, MBWS is doing worse than 69.57% of the companies in the same industry.
In the last couple of years the Gross Margin of MBWS has remained more or less at the same level.
Industry RankSector Rank
OM 4.72%
PM (TTM) 5.12%
GM 39.05%
OM growth 3Y42.97%
OM growth 5YN/A
PM growth 3Y15.32%
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5Y-1.12%
MBWS.PA Yearly Profit, Operating, Gross MarginsMBWS.PA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

8

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), MBWS is destroying value.
There is no outstanding debt for MBWS. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
MBWS.PA Yearly Shares OutstandingMBWS.PA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
MBWS.PA Yearly Total Debt VS Total AssetsMBWS.PA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 100M 200M 300M 400M

2.2 Solvency

An Altman-Z score of 4.27 indicates that MBWS is not in any danger for bankruptcy at the moment.
The Altman-Z score of MBWS (4.27) is better than 86.96% of its industry peers.
MBWS has a debt to FCF ratio of 0.82. This is a very positive value and a sign of high solvency as it would only need 0.82 years to pay back of all of its debts.
MBWS's Debt to FCF ratio of 0.82 is amongst the best of the industry. MBWS outperforms 95.65% of its industry peers.
A Debt/Equity ratio of 0.03 indicates that MBWS is not too dependend on debt financing.
The Debt to Equity ratio of MBWS (0.03) is better than 95.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.82
Altman-Z 4.27
ROIC/WACC0.41
WACC7.86%
MBWS.PA Yearly LT Debt VS Equity VS FCFMBWS.PA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M

2.3 Liquidity

A Current Ratio of 2.71 indicates that MBWS has no problem at all paying its short term obligations.
The Current ratio of MBWS (2.71) is better than 91.30% of its industry peers.
A Quick Ratio of 1.84 indicates that MBWS should not have too much problems paying its short term obligations.
With an excellent Quick ratio value of 1.84, MBWS belongs to the best of the industry, outperforming 100.00% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 2.71
Quick Ratio 1.84
MBWS.PA Yearly Current Assets VS Current LiabilitesMBWS.PA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M 250M

3

3. Growth

3.1 Past

MBWS shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 10.51%, which is quite good.
Measured over the past years, MBWS shows a quite strong growth in Earnings Per Share. The EPS has been growing by 11.49% on average per year.
MBWS shows a decrease in Revenue. In the last year, the revenue decreased by -3.00%.
MBWS shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 2.46% yearly.
EPS 1Y (TTM)10.51%
EPS 3Y11.49%
EPS 5YN/A
EPS Q2Q%-13.89%
Revenue 1Y (TTM)-3%
Revenue growth 3Y4.17%
Revenue growth 5Y2.46%
Sales Q2Q%-2.1%

3.2 Future

MBWS is expected to show a decrease in Earnings Per Share. In the coming years, the EPS will decrease by 0.00% yearly.
Based on estimates for the next years, MBWS will show a small growth in Revenue. The Revenue will grow by 2.76% on average per year.
EPS Next Y-12.5%
EPS Next 2Y0%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year2.13%
Revenue Next 2Y2.63%
Revenue Next 3Y2.76%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
MBWS.PA Yearly Revenue VS EstimatesMBWS.PA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M
MBWS.PA Yearly EPS VS EstimatesMBWS.PA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 0 -0.5 -1 -1.5

0

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 33.78, the valuation of MBWS can be described as expensive.
MBWS's Price/Earnings ratio is a bit more expensive when compared to the industry. MBWS is more expensive than 73.91% of the companies in the same industry.
When comparing the Price/Earnings ratio of MBWS to the average of the S&P500 Index (27.41), we can say MBWS is valued slightly more expensively.
Based on the Price/Forward Earnings ratio of 42.58, the valuation of MBWS can be described as expensive.
86.96% of the companies in the same industry are cheaper than MBWS, based on the Price/Forward Earnings ratio.
MBWS is valuated rather expensively when we compare the Price/Forward Earnings ratio to 35.19, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 33.78
Fwd PE 42.58
MBWS.PA Price Earnings VS Forward Price EarningsMBWS.PA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

MBWS's Enterprise Value to EBITDA ratio is rather expensive when compared to the industry. MBWS is more expensive than 86.96% of the companies in the same industry.
MBWS's Price/Free Cash Flow ratio is a bit more expensive when compared to the industry. MBWS is more expensive than 69.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 36.66
EV/EBITDA 21.09
MBWS.PA Per share dataMBWS.PA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0.5 1 1.5

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y0%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

No dividends for MBWS!.
Industry RankSector Rank
Dividend Yield N/A

MARIE BRIZARD WINE & SPIRITS

EPA:MBWS (7/11/2025, 7:00:00 PM)

3.04

-0.01 (-0.33%)

Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryBeverages
Earnings (Last)04-24 2025-04-24
Earnings (Next)07-23 2025-07-23
Inst Owners3.74%
Inst Owner ChangeN/A
Ins Owners0.01%
Ins Owner ChangeN/A
Market Cap340.45M
Analysts42.22
Price Target3.37 (10.86%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)-1.54%
Valuation
Industry RankSector Rank
PE 33.78
Fwd PE 42.58
P/S 1.81
P/FCF 36.66
P/OCF 21.03
P/B 1.59
P/tB 2.73
EV/EBITDA 21.09
EPS(TTM)0.09
EY2.96%
EPS(NY)0.07
Fwd EY2.35%
FCF(TTM)0.08
FCFY2.73%
OCF(TTM)0.14
OCFY4.75%
SpS1.68
BVpS1.91
TBVpS1.11
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 3.46%
ROE 4.52%
ROCE 3.98%
ROIC 3.24%
ROICexc 4.3%
ROICexgc 8.98%
OM 4.72%
PM (TTM) 5.12%
GM 39.05%
FCFM 4.93%
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3Y42.97%
OM growth 5YN/A
PM growth 3Y15.32%
PM growth 5YN/A
GM growth 3Y-1.72%
GM growth 5Y-1.12%
F-Score6
Asset Turnover0.68
Health
Industry RankSector Rank
Debt/Equity 0.03
Debt/FCF 0.82
Debt/EBITDA 0.5
Cap/Depr 144.28%
Cap/Sales 3.66%
Interest Coverage 250
Cash Conversion 118.37%
Profit Quality 96.28%
Current Ratio 2.71
Quick Ratio 1.84
Altman-Z 4.27
F-Score6
WACC7.86%
ROIC/WACC0.41
Cap/Depr(3y)199.06%
Cap/Depr(5y)172.98%
Cap/Sales(3y)2.69%
Cap/Sales(5y)2.6%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)10.51%
EPS 3Y11.49%
EPS 5YN/A
EPS Q2Q%-13.89%
EPS Next Y-12.5%
EPS Next 2Y0%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3%
Revenue growth 3Y4.17%
Revenue growth 5Y2.46%
Sales Q2Q%-2.1%
Revenue Next Year2.13%
Revenue Next 2Y2.63%
Revenue Next 3Y2.76%
Revenue Next 5YN/A
EBIT growth 1Y10.35%
EBIT growth 3Y48.93%
EBIT growth 5YN/A
EBIT Next Year55.56%
EBIT Next 3Y21.14%
EBIT Next 5YN/A
FCF growth 1Y366.23%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y896.74%
OCF growth 3YN/A
OCF growth 5YN/A